125 related articles for article (PubMed ID: 23991464)
1. Ukrain and its emerging role as an antineoplastic agent in systemic malignancies.
Kapoor S
Exp Oncol; 2013 Jun; 35(2):127. PubMed ID: 23991464
[No Abstract] [Full Text] [Related]
2. Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice.
Bozeman EN; Srivatsan S; Mohammadi H; Daniels D; Shashidharamurthy R; Selvaraj P
Exp Oncol; 2012 Dec; 34(4):340-7. PubMed ID: 23302993
[TBL] [Abstract][Full Text] [Related]
3. Anticancer agent ukrain and bortezomib combination is synergistic in 4T1 breast cancer cells.
Savran B; Yerlikaya A; Erdoğan E; Genç O
Anticancer Agents Med Chem; 2014 Mar; 14(3):466-72. PubMed ID: 23919744
[TBL] [Abstract][Full Text] [Related]
4. Synergic influence of Ukrain and protoporphyrin amino acid conjugates on human malignant cell lines.
Brzosko WJ; Graczyk A; Konarski J; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):193-4. PubMed ID: 8899329
[TBL] [Abstract][Full Text] [Related]
5. Effects of ukrain in rats with intestinal ischemia and reperfusion.
Akcilar R; Akcilar A; Savran B; Ayada C; Koçak C; Koçak FE; Genç O
J Surg Res; 2015 May; 195(1):67-73. PubMed ID: 25636256
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB does not influence the induction of apoptosis by Ukrain.
Mendoza J; Zamora R; Gallardo JC; Ceballos G; Aldana A; Espinosa M; Maldonado V; Melendez-Zajgla J
Cancer Biol Ther; 2006 Jul; 5(7):788-93. PubMed ID: 16721042
[TBL] [Abstract][Full Text] [Related]
7. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
[TBL] [Abstract][Full Text] [Related]
8. The effect of NSC-631570 (ukrain) alone and in combination with pathogen-associated molecules on cell cycle distribution and apoptosis induction of mouse melanoma cells with different biological properties.
Skivka LM; Trompak OO; Kudryavets YI; Bezdenezhnykh NA; Susak YM
Exp Oncol; 2010 Jul; 32(2):92-6. PubMed ID: 20693969
[TBL] [Abstract][Full Text] [Related]
9. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro.
Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M
Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470
[TBL] [Abstract][Full Text] [Related]
10. Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain.
Deneka ER
Drugs Exp Clin Res; 1998; 24(5-6):281-5. PubMed ID: 10190088
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Magnani I; Bertelli AA; Nowicky W; Gioia M
Anticancer Drugs; 2006 Feb; 17(2):189-94. PubMed ID: 16428937
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro.
Gagliano N; Volpari T; Clerici M; Pettinari L; Barajon I; Portinaro N; Colombo G; Milzani A; Dalle-Donne I; Martinelli C
Anticancer Drugs; 2012 Oct; 23(9):935-46. PubMed ID: 22700003
[TBL] [Abstract][Full Text] [Related]
13. [Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin cytoskeleton of macrophages].
Mozhenok TP; Beliaeva TN; Leont'eva EA; Faddeeva MD
Tsitologiia; 2005; 47(10):860-5. PubMed ID: 16711384
[TBL] [Abstract][Full Text] [Related]
14. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
[TBL] [Abstract][Full Text] [Related]
15. Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice.
Jagiello-Wójtowicz E; Kleinrok Z; Gustaw K
Drugs Exp Clin Res; 1998; 24(5-6):327-30. PubMed ID: 10190097
[TBL] [Abstract][Full Text] [Related]
16. Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones.
Jagiello-Wójtowicz E; Kleinrok Z; Feldo M; Chodkowska A; Szklarczyk V; Urbanska EM
Drugs Exp Clin Res; 1998; 24(5-6):305-8. PubMed ID: 10190092
[TBL] [Abstract][Full Text] [Related]
17. Study of the antitumor effect of Ukrain: the role of macrophage secretion of alpha-1-proteinase inhibitor.
Korolenko TA; Kaledin VI; Svechnikova IG; Li XV; Stashko JF; Ilnitskaya SI; Nikolin VP
Drugs Exp Clin Res; 1998; 24(5-6):271-6. PubMed ID: 10190086
[TBL] [Abstract][Full Text] [Related]
18. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human pregnancy plasma diamine oxidase with alkaloids of Argemone mexicana--berberine and sanguinarine.
Vaidya AB; Rajagopalan TG; Kale AG; Levine RJ
J Postgrad Med; 1980 Jan; 26(1):28-33. PubMed ID: 6768879
[No Abstract] [Full Text] [Related]
20. Influence of Ukrain on the redox processes of hepatocytes.
Zhalilo LI; Susak YM; Zemskov SV; Susak IA
Drugs Exp Clin Res; 1996; 22(3-5):189-91. PubMed ID: 8899328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
